» Articles » PMID: 35308568

Identification of Potential Ferroptosis-Related Biomarkers and Immune Infiltration in Human Coronary Artery Atherosclerosis

Overview
Journal Int J Gen Med
Publisher Dove Medical Press
Specialty General Medicine
Date 2022 Mar 21
PMID 35308568
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Ferroptosis is a specific subtype of programmed cell death, which plays an essential role in the immune-associated disease, atherosclerosis (AS). The purpose of this study was to identify potential ferroptosis-related gene biomarkers and its association with immune infiltration characteristics in atherosclerosis with bioinformatics methods.

Methods: Differentially expressed genes (DEGs) between AS and control groups were screened from GSE40231, analyzed for functional enrichment and then intersected with ferroptosis-related genes. Then, a random forest model was constructed based on these differentially expressed ferroptosis-related genes (DE-FRGs) and validated with dataset GSE132651. The performance of the models was evaluated with the area under receiver operating characteristic curves (AUC). Finally, we analyzed the correlation between DE-FRGs above and the characteristics of immune infiltration via CIBERSORT method.

Results: Six DE-FRGs (IL6, ANGPTL7, CDKN1A, AKR1C3, NOX4 and VLDLR) were detected based on dataset of GSE40231. Furthermore, a random forest model was constructed based on them with a compelling diagnostic performance of AUC = 0.8974 in the validation dataset GSE132651. In addition, the proportion of follicular helper T (Tfh) cells was significantly higher in AS group (P < 0.001). And we found significant correlation relationship between Tfh and expression level of ANGPTL7 (R = 0.35, P < 0.01), CDKN1A (R = 0.4, P < 0.0001), AKR1C3 (R = 0.64, P < 0.0001), NOX4 (R = 0.32, P < 0.01) and VLDLR (R = -0.43, P < 0.0001).

Conclusion: This study identified 6 DE-FRGs and validated a predicted model for the early prediction of AS, which also proved the close relationship between ferroptosis and immunity in the pathogenesis of AS.

Citing Articles

Identification of CAPG as a potential prognostic biomarker associated with immune cell infiltration and ferroptosis in uterine corpus endometrial carcinoma.

Liu J, Zhu W, Xia L, Zhu Q, Mao Y, Shen Y Front Endocrinol (Lausanne). 2024; 15:1452219.

PMID: 39600941 PMC: 11588481. DOI: 10.3389/fendo.2024.1452219.


Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets.

De Meyer G, Zurek M, Puylaert P, Martinet W Nat Rev Cardiol. 2024; 21(5):312-325.

PMID: 38163815 DOI: 10.1038/s41569-023-00957-0.


IL‑37 suppresses macrophage ferroptosis to attenuate diabetic atherosclerosis via the NRF2 pathway.

Xu J, Han X, Xia N, Zhao Q, Cheng Z Exp Ther Med. 2023; 25(6):289.

PMID: 37206550 PMC: 10189585. DOI: 10.3892/etm.2023.11988.


Identification of immune-related biomarkers and construction of regulatory network in patients with atherosclerosis.

Dong R, Jiang G, Tian Y, Shi X BMC Med Genomics. 2022; 15(1):245.

PMID: 36437453 PMC: 9703734. DOI: 10.1186/s12920-022-01397-4.

References
1.
Yang K, Song H, Yin D . PDSS2 Inhibits the Ferroptosis of Vascular Endothelial Cells in Atherosclerosis by Activating Nrf2. J Cardiovasc Pharmacol. 2021; 77(6):767-776. PMC: 8274586. DOI: 10.1097/FJC.0000000000001030. View

2.
Rigatti S . Random Forest. J Insur Med. 2017; 47(1):31-39. DOI: 10.17849/insm-47-01-31-39.1. View

3.
Ritchie M, Phipson B, Wu D, Hu Y, Law C, Shi W . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. PMC: 4402510. DOI: 10.1093/nar/gkv007. View

4.
Yang Z, Simari R, Perkins N, San H, Gordon D, Nabel G . Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci U S A. 1996; 93(15):7905-10. PMC: 38847. DOI: 10.1073/pnas.93.15.7905. View

5.
Green D . The Coming Decade of Cell Death Research: Five Riddles. Cell. 2019; 177(5):1094-1107. PMC: 6534278. DOI: 10.1016/j.cell.2019.04.024. View